Insider trading · Q3 2026 · CIK 1136869

Zimmer Biomet Holdings, Inc. (ZBH) insider trading.

In Q3 2026, insiders at Zimmer Biomet Holdings, Inc. reported 4 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $824K.

Transactions
4
Purchases (P)
0
Sales (S)
2
Net shares, P minus S
-8,691
Insiders
2
Last filed
2026-09-15

Insiders

InsiderRelationshipTransactionsBuysSales
Thornal Kevin ROfficer · Grp Pres-Global Business301
Phipps Chad FOfficer · See remarks below.101

Transactions

4 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-11Thornal Kevin RS (D)5,691$92.950Form 4
2026-09-04Phipps Chad FS (D)3,000$98.3565,231Form 4
2026-08-01Thornal Kevin RM (A)9,957$09,957Form 4
2026-08-01Thornal Kevin RF (D)4,266$92.685,691Form 4

Transaction codes in this quarter

Get ZBH insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1136869&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · ZBH company page · Zimmer Biomet Holdings, Inc. on SEC.gov

Questions

Are insiders buying or selling Zimmer Biomet Holdings, Inc. (ZBH)?

In Q3 2026, insiders at Zimmer Biomet Holdings, Inc. reported 4 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $824K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Zimmer Biomet Holdings, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/zbh.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.